China Sxt Pharmaceuticals Inc (SXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2007 | |
| Sales | 5,162 | 7,012 | 7,019 | 4,882 | 0 |
| Cost of Goods | 2,459 | 2,401 | 3,618 | 2,570 | N/A |
| Gross Profit | 2,704 | 4,612 | 3,402 | 2,312 | N/A |
| Operating Expenses | 4,503 | 3,243 | 2,387 | 1,279 | 0 |
| Operating Income | -1,341 | 1,770 | 1,632 | 1,602 | N/A |
| Interest Expense | 3,349 | 5 | 1 | 40 | 0 |
| Other Income | -5,700 | 27 | -4 | 18 | 0 |
| Pre-tax Income | -10,390 | 1,792 | 1,628 | 1,580 | 0 |
| Income Tax | -102 | 252 | 440 | 395 | N/A |
| Net Income Continuous | -10,288 | 1,539 | 1,188 | 1,185 | N/A |
| Net Income | $-10,288 | $1,539 | $1,188 | $1,185 | $N/A |
| EPS Basic Total Ops | -6,656.00 | 1,200.00 | 944.00 | 944.00 | N/A |
| EPS Basic Continuous Ops | -6,656.66 | 1,197.32 | 950.06 | 948.12 | N/A |
| EPS Diluted Total Ops | -6,656.00 | 1,200.00 | 944.00 | 944.00 | N/A |
| EPS Diluted Continuous Ops | -6,656.66 | 1,197.32 | 950.06 | 948.12 | N/A |
| EPS Diluted Before Non-Recurring Items | -3,040.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,009 | $1,950 | $1,762 | $1,701 | $N/A |